ProCE Banner Activity

Doxycycline Postexposure Prophylaxis for STI Prevention in People on HIV PrEP Presenting for Sexual Health Visits

Conference Coverage
Slideset

In an observational study at a San Francisco sexual health clinic, people on HIV pre-exposure prophylaxis who initiated doxycycline postexposure prophylaxis saw significant and sustained decreases in chlamydia, syphilis, and gonorrhea cases.

Released: March 14, 2025

Expiration: September 13, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare